Acute Interstitial Pneumonitis: Case Series and Review of the Literature

Acute interstitial pneumonitis (AIP) is an acute, idiopathic interstitial lung disease characterized by rapidly progressive diffuse pulmonary infiltrates and hypoxemia requiring hospitalization. The case-fatality ratio is high. Previous reports suggested that survivors of the acute event have a favorable outcome. We undertook this study to examine the natural history of survivors. We had observed several patients who experienced recurrent episodes of AIP and chronic progressive interstitial lung disease. We sought to determine longitudinal survival in these patients and to compare our experience with that in the medical literature. Overall, we identified 13 biopsy-proven cases of AIP. The mean patient age was 54 years in our review, which is identical to previous reports. Twelve patients were hospitalized and all 12 required mechanical ventilation. Overall hospital survival was 67%. All patients demonstrated abnormalities in gas exchange at presentation. Radiographs typically demonstrated bilateral patchy densities that progressed to a diffuse alveolar filling pattern in nearly all cases. All biopsy specimens showed organizing diffuse alveolar damage. Longitudinal data were available for 7 patients. Two died of AIP recurrences. A third died of complications of heart failure shortly after hospital discharge. One patient progressed to end-stage lung disease and required lung transplantation. Two patients experienced persistent pulmonary symptoms, accompanied in 1 by progressive lung fibrosis. One patient had nearly complete recovery of lung function 2 years following AIP. (Follow-up information was unavailable for 2 survivors.) In our literature review, 5 of 7 patients reported experienced some recovery of lung function. One case of progressive interstitial lung disease requiring lung transplantation was reported. The reported mortality was much higher than in our experience (74% versus 33%). The mean time from symptom onset to death was 26 days, compared with 34 days in our experience. The use of corticosteroids did not appear to influence survival, although this has not been tested in a rigorous manner. The better survival in our series may be related in part to a survivor selection bias. In contrast to previous reports, we found that survivors of AIP may experience recurrences and chronic, progressive interstitial lung disease. We did not identify any clinical or pathologic features that predict mortality in these patients. Likewise, there were no features that predicted the longitudinal course in survivors. Further study to identify causal factors is required in the hope of preventing morbidity and mortality related to this disease.

[1]  K. Rowan,et al.  Outcome data and scoring systems , 1999, BMJ.

[2]  N. Müller,et al.  Acute interstitial pneumonia: radiographic and CT findings in nine patients. , 1993, Radiology.

[3]  M. Schwarz The acute (noninfectious) interstitial lung diseases. , 1996, Comprehensive therapy.

[4]  A. Burkhardt,et al.  Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. , 1989, The American review of respiratory disease.

[5]  G. Meduri,et al.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.

[6]  T. King,et al.  An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. , 1989, The American review of respiratory disease.

[7]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[8]  J. Tomashefski,et al.  Regional alveolar damage (RAD). A localized counterpart of diffuse alveolar damage. , 1989, American journal of clinical pathology.

[9]  V. Ferrans,et al.  Intraluminal fibrosis in interstitial lung disorders. , 1986, The American journal of pathology.

[10]  N. Müller,et al.  Acute interstitial pneumonia: thin-section CT findings in 36 patients. , 1999, Radiology.

[11]  F. Askin Back to the future: the Hamman-Rich syndrome and acute interstitial pneumonia. , 1990, Mayo Clinic proceedings.

[12]  G. Rubenfeld,et al.  The effect of acute respiratory distress syndrome on long-term survival. , 1999, American journal of respiratory and critical care medicine.

[13]  J. Ikezoe,et al.  Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. , 1997, AJR. American journal of roentgenology.

[14]  H. Winer-Muram,et al.  The fibroproliferative phase of late adult respiratory distress syndrome. , 1995, Seminars in respiratory infections.

[15]  J. May,et al.  Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. , 1979, Thorax.

[16]  J. D. Smith,et al.  Variability in lung collagen amounts after prolonged support of acute respiratory failure. , 1984, Chest.

[17]  A. Katzenstein,et al.  Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.

[18]  R. D. du Bois,et al.  Acute interstitial pneumonia. , 2000, The European respiratory journal.

[19]  T. Colby,et al.  Hamman-Rich syndrome revisited. , 1990, Mayo Clinic proceedings.

[20]  S. Gravenstein,et al.  A Rhinovirus Outbreak among Residents of a Long-Term Care Facility , 1995, Annals of Internal Medicine.

[21]  D. Geddes,et al.  Partial resolution of acute interstitial pneumonia in native lung after single lung transplantation. , 1996, Thorax.

[22]  J. Myers,et al.  Acute Interstitial Pneumonia: A Clinicopathologic, Ultrastmctural, and Cell Kinetic Study , 1986, The American journal of surgical pathology.

[23]  R B Schoene,et al.  Recovery of function in survivors of the acute respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.